ArticleCancers2022

Both In Situ and Circulating SLC3A2 Could Be Used as Prognostic Markers for Human Lung Squamous Cell Carcinoma and Lung Adenocarcinoma.

Dahua Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.